Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers

Identification of BRCA mutations in breast cancer (BC) patients influences treatment and survival and may be of importance for their relatives. Testing is often restricted to women fulfilling high-risk criteria.